Organization: Health Canada
Year: 2023
Month: September
Request Number: A-2023-000451
Request Summary: Adverse Drug Reaction (ADR) for DEXILANT. Report number: E2B_06317830. ADRs for ENTYVIO. Report numbers: 001037118, E2B_06297130, 001035880. ADRs for ONDANSETRON. Report numbers: E2B_06293443, E2B_06298982, E2B_06333994, E2B_06304558, E2B_06322121, 001038353.
Disposition: Disclosed in part
Number of pages: 138